Modelled DT Structure
Method: homology modeling
Template PDB: 4YZF_A
Identity: 55.773%
Minimized Score: -1810.804 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0384 | ||||
| Gene Name | SLC4A3 | ||||
| Protein Name | Anion exchange protein 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 4YZF_A Identity: 55.773% Minimized Score: -1810.804 kcal/mol Detail: Structure Info |
||||
| Synonyms | AE 3; AE3; Anion exchanger 3; CAE3/BAE3; Cardiac/brain band 3-like protein; Neuronal band 3-like protein; SLC2C; SLC4A3; Solute carrier family 4 member 3 | ||||
| DT Family | Anion Exchanger (AE) Family ; | ||||
| Tissue Specificity | Both BAE3 and CAE3 are expressed in failingventricle. | ||||
| Function | This transporter is a plasma membrane anion exchange protein of wide distribution. Mediates at least a part of the Cl(-)/HCO3(-) exchange in cardiac myocytes. Both BAE3 and CAE3 forms transport Cl(-). | ||||
| Endogenous Substrate(s) | Anions | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Clinical Trial Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Bicarbonate
|
Phase 3 | Drug Info | Metabolic acidosis | 5C73 | [1] |
| References | |||||
| 1 | The SLC4 family of bicarbonate (HCO??) transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):159-82. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.